CDK2 and urinary bladder carcinoma: Down-regulation of CDK1 has been shown by others to contribute to an S-phase arrest in bladder cancer cells [33], although Aranha et al. pointed to dephosphorylating CDK2 as the relevant mechanism for arresting bladder cancer cells at the S/G2/M checkpoints [34].